
    
      The Investigators will enroll only women with an etonogestrel contraceptive implant in place
      who are initiating isotretinoin therapy through their dermatologist. The Investigators will
      monitor the subjects serum etonogestrel concentration during isotretinoin therapy but no
      medications will be provided through this study. No medical devices will be inserted as part
      of this study either.
    
  